Page last updated: 2024-10-27

fluoxetine and Heart Septal Defects, Ventricular

fluoxetine has been researched along with Heart Septal Defects, Ventricular in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.

Research Excerpts

ExcerptRelevanceReference
"Fluoxetine was associated with an increased risk of isolated ventricular septal defects (adjusted OR 2."1.37Selective serotonin reuptake inhibitors and risk for major congenital anomalies. ( Artama, M; Gissler, M; Malm, H; Ritvanen, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malm, H1
Artama, M1
Gissler, M1
Ritvanen, A1

Other Studies

1 other study available for fluoxetine and Heart Septal Defects, Ventricular

ArticleYear
Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Alcohol Drinking; Female; Finland; Fluoxetine; Heart

2011